How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

A Brazil special: we hear from Sérgio Dávila, editor in chief of ‘Folha de São Paulo’ and Catarina Carvalho, executive director of ‘Piaui’ magazine. At the Arab Media Summit, we join AFP’s global news ...

This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed. The above button links to ...

Recursion Pharmaceuticals logged 5 insider transactions totaling $514,889.42. Activity was led by 4 tax payments worth $436,067.04 and 1 sale worth $78,822.38. Ben R Taylor recorded 2 tax payments ...